[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Antithyroid Drug Market Growth (Status and Outlook) 2023-2029

March 2023 | 120 pages | ID: G5171885CB90EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Antithyroid drug is a drug for the treatment of hyperthyroidism. It mainly reduces the secretion of thyroid hormone by inhibiting thyroid synthesis.

LPI (LP Information)' newest research report, the “Antithyroid Drug Industry Forecast” looks at past sales and reviews total world Antithyroid Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Antithyroid Drug sales for 2023 through 2029. With Antithyroid Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antithyroid Drug industry.

This Insight Report provides a comprehensive analysis of the global Antithyroid Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antithyroid Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antithyroid Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antithyroid Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antithyroid Drug.

The global Antithyroid Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

The next decade will be full of promise in thyroid cancer diagnosis and treatment.With the increasing incidence of thyroid cancer, the scientific cognition of professionals and the public will also be further improved. There will be more investment in basic research, more targeted drugs will be developed and better drug efficacy will be achieved.Therefore, the anti-thyroid drug market still has a lot of room for growth in the future.

This report presents a comprehensive overview, market shares, and growth opportunities of Antithyroid Drug market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Thiourea
  • Iodine and Iodide
  • Radioiodine
  • ? Receptor Blockers
Segmentation by application
  • Medical Treatment of Hyperthyroidism
  • Preparation for Thyroid Surgery
  • Treatment of Thyroid Crisis
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Shanghai Huanghai Pharmaceutical Co., Ltd
  • Merck KGaA
  • Lomapharm Rudolf Lohmann GmbH KG
  • Herbrand Pharmaceutical Chemistry Co., Ltd
  • Beijing Tongjida Pharmaceutical Co., Ltd
  • Shanghai Zhaohui Pharmaceutical Co., Ltd
  • Guangzhou Kanghe Pharmaceutical Co., Ltd
  • Hunan Hansen Pharmaceutical Co., Ltd
  • World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
  • Haimani Pharmaceutical Co., Ltd
  • Shanghai McLin Biochemical Technology Co., Ltd
  • Shanghai Yuanye Bio-Technology Co., Ltd
  • Amgen Inc
  • AbbVie Deutschland GmbH & Co.KG
  • Centrix Pharmaceutical Inc.
  • Pfizer Inc.
  • Actavis Totowa LLC
  • Caraco Pharmaceutical Laboratories
  • Boca Pharmacal Inc.
  • Heritage Pharmaceuticals Inc.
  • Par Pharmaceutical Inc
  • Sandoz Pharmaceuticals Inc.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antithyroid Drug Market Size 2018-2029
  2.1.2 Antithyroid Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Antithyroid Drug Segment by Type
  2.2.1 Thiourea
  2.2.2 Iodine and Iodide
  2.2.3 Radioiodine
  2.2.4 ? Receptor Blockers
2.3 Antithyroid Drug Market Size by Type
  2.3.1 Antithyroid Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Antithyroid Drug Market Size Market Share by Type (2018-2023)
2.4 Antithyroid Drug Segment by Application
  2.4.1 Medical Treatment of Hyperthyroidism
  2.4.2 Preparation for Thyroid Surgery
  2.4.3 Treatment of Thyroid Crisis
2.5 Antithyroid Drug Market Size by Application
  2.5.1 Antithyroid Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Antithyroid Drug Market Size Market Share by Application (2018-2023)

3 ANTITHYROID DRUG MARKET SIZE BY PLAYER

3.1 Antithyroid Drug Market Size Market Share by Players
  3.1.1 Global Antithyroid Drug Revenue by Players (2018-2023)
  3.1.2 Global Antithyroid Drug Revenue Market Share by Players (2018-2023)
3.2 Global Antithyroid Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTITHYROID DRUG BY REGIONS

4.1 Antithyroid Drug Market Size by Regions (2018-2023)
4.2 Americas Antithyroid Drug Market Size Growth (2018-2023)
4.3 APAC Antithyroid Drug Market Size Growth (2018-2023)
4.4 Europe Antithyroid Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Antithyroid Drug Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Antithyroid Drug Market Size by Country (2018-2023)
5.2 Americas Antithyroid Drug Market Size by Type (2018-2023)
5.3 Americas Antithyroid Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antithyroid Drug Market Size by Region (2018-2023)
6.2 APAC Antithyroid Drug Market Size by Type (2018-2023)
6.3 APAC Antithyroid Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Antithyroid Drug by Country (2018-2023)
7.2 Europe Antithyroid Drug Market Size by Type (2018-2023)
7.3 Europe Antithyroid Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antithyroid Drug by Region (2018-2023)
8.2 Middle East & Africa Antithyroid Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Antithyroid Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTITHYROID DRUG MARKET FORECAST

10.1 Global Antithyroid Drug Forecast by Regions (2024-2029)
  10.1.1 Global Antithyroid Drug Forecast by Regions (2024-2029)
  10.1.2 Americas Antithyroid Drug Forecast
  10.1.3 APAC Antithyroid Drug Forecast
  10.1.4 Europe Antithyroid Drug Forecast
  10.1.5 Middle East & Africa Antithyroid Drug Forecast
10.2 Americas Antithyroid Drug Forecast by Country (2024-2029)
  10.2.1 United States Antithyroid Drug Market Forecast
  10.2.2 Canada Antithyroid Drug Market Forecast
  10.2.3 Mexico Antithyroid Drug Market Forecast
  10.2.4 Brazil Antithyroid Drug Market Forecast
10.3 APAC Antithyroid Drug Forecast by Region (2024-2029)
  10.3.1 China Antithyroid Drug Market Forecast
  10.3.2 Japan Antithyroid Drug Market Forecast
  10.3.3 Korea Antithyroid Drug Market Forecast
  10.3.4 Southeast Asia Antithyroid Drug Market Forecast
  10.3.5 India Antithyroid Drug Market Forecast
  10.3.6 Australia Antithyroid Drug Market Forecast
10.4 Europe Antithyroid Drug Forecast by Country (2024-2029)
  10.4.1 Germany Antithyroid Drug Market Forecast
  10.4.2 France Antithyroid Drug Market Forecast
  10.4.3 UK Antithyroid Drug Market Forecast
  10.4.4 Italy Antithyroid Drug Market Forecast
  10.4.5 Russia Antithyroid Drug Market Forecast
10.5 Middle East & Africa Antithyroid Drug Forecast by Region (2024-2029)
  10.5.1 Egypt Antithyroid Drug Market Forecast
  10.5.2 South Africa Antithyroid Drug Market Forecast
  10.5.3 Israel Antithyroid Drug Market Forecast
  10.5.4 Turkey Antithyroid Drug Market Forecast
  10.5.5 GCC Countries Antithyroid Drug Market Forecast
10.6 Global Antithyroid Drug Forecast by Type (2024-2029)
10.7 Global Antithyroid Drug Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Shanghai Huanghai Pharmaceutical Co., Ltd
  11.1.1 Shanghai Huanghai Pharmaceutical Co., Ltd Company Information
  11.1.2 Shanghai Huanghai Pharmaceutical Co., Ltd Antithyroid Drug Product Offered
  11.1.3 Shanghai Huanghai Pharmaceutical Co., Ltd Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Shanghai Huanghai Pharmaceutical Co., Ltd Main Business Overview
  11.1.5 Shanghai Huanghai Pharmaceutical Co., Ltd Latest Developments
11.2 Merck KGaA
  11.2.1 Merck KGaA Company Information
  11.2.2 Merck KGaA Antithyroid Drug Product Offered
  11.2.3 Merck KGaA Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Merck KGaA Main Business Overview
  11.2.5 Merck KGaA Latest Developments
11.3 Lomapharm Rudolf Lohmann GmbH KG
  11.3.1 Lomapharm Rudolf Lohmann GmbH KG Company Information
  11.3.2 Lomapharm Rudolf Lohmann GmbH KG Antithyroid Drug Product Offered
  11.3.3 Lomapharm Rudolf Lohmann GmbH KG Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Lomapharm Rudolf Lohmann GmbH KG Main Business Overview
  11.3.5 Lomapharm Rudolf Lohmann GmbH KG Latest Developments
11.4 Herbrand Pharmaceutical Chemistry Co., Ltd
  11.4.1 Herbrand Pharmaceutical Chemistry Co., Ltd Company Information
  11.4.2 Herbrand Pharmaceutical Chemistry Co., Ltd Antithyroid Drug Product Offered
  11.4.3 Herbrand Pharmaceutical Chemistry Co., Ltd Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Herbrand Pharmaceutical Chemistry Co., Ltd Main Business Overview
  11.4.5 Herbrand Pharmaceutical Chemistry Co., Ltd Latest Developments
11.5 Beijing Tongjida Pharmaceutical Co., Ltd
  11.5.1 Beijing Tongjida Pharmaceutical Co., Ltd Company Information
  11.5.2 Beijing Tongjida Pharmaceutical Co., Ltd Antithyroid Drug Product Offered
  11.5.3 Beijing Tongjida Pharmaceutical Co., Ltd Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Beijing Tongjida Pharmaceutical Co., Ltd Main Business Overview
  11.5.5 Beijing Tongjida Pharmaceutical Co., Ltd Latest Developments
11.6 Shanghai Zhaohui Pharmaceutical Co., Ltd
  11.6.1 Shanghai Zhaohui Pharmaceutical Co., Ltd Company Information
  11.6.2 Shanghai Zhaohui Pharmaceutical Co., Ltd Antithyroid Drug Product Offered
  11.6.3 Shanghai Zhaohui Pharmaceutical Co., Ltd Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Shanghai Zhaohui Pharmaceutical Co., Ltd Main Business Overview
  11.6.5 Shanghai Zhaohui Pharmaceutical Co., Ltd Latest Developments
11.7 Guangzhou Kanghe Pharmaceutical Co., Ltd
  11.7.1 Guangzhou Kanghe Pharmaceutical Co., Ltd Company Information
  11.7.2 Guangzhou Kanghe Pharmaceutical Co., Ltd Antithyroid Drug Product Offered
  11.7.3 Guangzhou Kanghe Pharmaceutical Co., Ltd Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Guangzhou Kanghe Pharmaceutical Co., Ltd Main Business Overview
  11.7.5 Guangzhou Kanghe Pharmaceutical Co., Ltd Latest Developments
11.8 Hunan Hansen Pharmaceutical Co., Ltd
  11.8.1 Hunan Hansen Pharmaceutical Co., Ltd Company Information
  11.8.2 Hunan Hansen Pharmaceutical Co., Ltd Antithyroid Drug Product Offered
  11.8.3 Hunan Hansen Pharmaceutical Co., Ltd Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Hunan Hansen Pharmaceutical Co., Ltd Main Business Overview
  11.8.5 Hunan Hansen Pharmaceutical Co., Ltd Latest Developments
11.9 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
  11.9.1 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Company Information
  11.9.2 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Antithyroid Drug Product Offered
  11.9.3 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Main Business Overview
  11.9.5 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Latest Developments
11.10 Haimani Pharmaceutical Co., Ltd
  11.10.1 Haimani Pharmaceutical Co., Ltd Company Information
  11.10.2 Haimani Pharmaceutical Co., Ltd Antithyroid Drug Product Offered
  11.10.3 Haimani Pharmaceutical Co., Ltd Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Haimani Pharmaceutical Co., Ltd Main Business Overview
  11.10.5 Haimani Pharmaceutical Co., Ltd Latest Developments
11.11 Shanghai McLin Biochemical Technology Co., Ltd
  11.11.1 Shanghai McLin Biochemical Technology Co., Ltd Company Information
  11.11.2 Shanghai McLin Biochemical Technology Co., Ltd Antithyroid Drug Product Offered
  11.11.3 Shanghai McLin Biochemical Technology Co., Ltd Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Shanghai McLin Biochemical Technology Co., Ltd Main Business Overview
  11.11.5 Shanghai McLin Biochemical Technology Co., Ltd Latest Developments
11.12 Shanghai Yuanye Bio-Technology Co., Ltd
  11.12.1 Shanghai Yuanye Bio-Technology Co., Ltd Company Information
  11.12.2 Shanghai Yuanye Bio-Technology Co., Ltd Antithyroid Drug Product Offered
  11.12.3 Shanghai Yuanye Bio-Technology Co., Ltd Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Shanghai Yuanye Bio-Technology Co., Ltd Main Business Overview
  11.12.5 Shanghai Yuanye Bio-Technology Co., Ltd Latest Developments
11.13 Amgen Inc
  11.13.1 Amgen Inc Company Information
  11.13.2 Amgen Inc Antithyroid Drug Product Offered
  11.13.3 Amgen Inc Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Amgen Inc Main Business Overview
  11.13.5 Amgen Inc Latest Developments
11.14 AbbVie Deutschland GmbH & Co.KG
  11.14.1 AbbVie Deutschland GmbH & Co.KG Company Information
  11.14.2 AbbVie Deutschland GmbH & Co.KG Antithyroid Drug Product Offered
  11.14.3 AbbVie Deutschland GmbH & Co.KG Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.14.4 AbbVie Deutschland GmbH & Co.KG Main Business Overview
  11.14.5 AbbVie Deutschland GmbH & Co.KG Latest Developments
11.15 Centrix Pharmaceutical Inc.
  11.15.1 Centrix Pharmaceutical Inc. Company Information
  11.15.2 Centrix Pharmaceutical Inc. Antithyroid Drug Product Offered
  11.15.3 Centrix Pharmaceutical Inc. Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.15.4 Centrix Pharmaceutical Inc. Main Business Overview
  11.15.5 Centrix Pharmaceutical Inc. Latest Developments
11.16 Pfizer Inc.
  11.16.1 Pfizer Inc. Company Information
  11.16.2 Pfizer Inc. Antithyroid Drug Product Offered
  11.16.3 Pfizer Inc. Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.16.4 Pfizer Inc. Main Business Overview
  11.16.5 Pfizer Inc. Latest Developments
11.17 Actavis Totowa LLC
  11.17.1 Actavis Totowa LLC Company Information
  11.17.2 Actavis Totowa LLC Antithyroid Drug Product Offered
  11.17.3 Actavis Totowa LLC Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.17.4 Actavis Totowa LLC Main Business Overview
  11.17.5 Actavis Totowa LLC Latest Developments
11.18 Caraco Pharmaceutical Laboratories
  11.18.1 Caraco Pharmaceutical Laboratories Company Information
  11.18.2 Caraco Pharmaceutical Laboratories Antithyroid Drug Product Offered
  11.18.3 Caraco Pharmaceutical Laboratories Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.18.4 Caraco Pharmaceutical Laboratories Main Business Overview
  11.18.5 Caraco Pharmaceutical Laboratories Latest Developments
11.19 Boca Pharmacal Inc.
  11.19.1 Boca Pharmacal Inc. Company Information
  11.19.2 Boca Pharmacal Inc. Antithyroid Drug Product Offered
  11.19.3 Boca Pharmacal Inc. Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.19.4 Boca Pharmacal Inc. Main Business Overview
  11.19.5 Boca Pharmacal Inc. Latest Developments
11.20 Heritage Pharmaceuticals Inc.
  11.20.1 Heritage Pharmaceuticals Inc. Company Information
  11.20.2 Heritage Pharmaceuticals Inc. Antithyroid Drug Product Offered
  11.20.3 Heritage Pharmaceuticals Inc. Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.20.4 Heritage Pharmaceuticals Inc. Main Business Overview
  11.20.5 Heritage Pharmaceuticals Inc. Latest Developments
11.21 Par Pharmaceutical Inc
  11.21.1 Par Pharmaceutical Inc Company Information
  11.21.2 Par Pharmaceutical Inc Antithyroid Drug Product Offered
  11.21.3 Par Pharmaceutical Inc Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.21.4 Par Pharmaceutical Inc Main Business Overview
  11.21.5 Par Pharmaceutical Inc Latest Developments
11.22 Sandoz Pharmaceuticals Inc.
  11.22.1 Sandoz Pharmaceuticals Inc. Company Information
  11.22.2 Sandoz Pharmaceuticals Inc. Antithyroid Drug Product Offered
  11.22.3 Sandoz Pharmaceuticals Inc. Antithyroid Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.22.4 Sandoz Pharmaceuticals Inc. Main Business Overview
  11.22.5 Sandoz Pharmaceuticals Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Antithyroid Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Thiourea
Table 3. Major Players of Iodine and Iodide
Table 4. Major Players of Radioiodine
Table 5. Major Players of ? Receptor Blockers
Table 6. Antithyroid Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Antithyroid Drug Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Antithyroid Drug Market Size Market Share by Type (2018-2023)
Table 9. Antithyroid Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Antithyroid Drug Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Antithyroid Drug Market Size Market Share by Application (2018-2023)
Table 12. Global Antithyroid Drug Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Antithyroid Drug Revenue Market Share by Player (2018-2023)
Table 14. Antithyroid Drug Key Players Head office and Products Offered
Table 15. Antithyroid Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antithyroid Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Antithyroid Drug Market Size Market Share by Regions (2018-2023)
Table 20. Global Antithyroid Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Antithyroid Drug Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Antithyroid Drug Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Antithyroid Drug Market Size Market Share by Country (2018-2023)
Table 24. Americas Antithyroid Drug Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Antithyroid Drug Market Size Market Share by Type (2018-2023)
Table 26. Americas Antithyroid Drug Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Antithyroid Drug Market Size Market Share by Application (2018-2023)
Table 28. APAC Antithyroid Drug Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Antithyroid Drug Market Size Market Share by Region (2018-2023)
Table 30. APAC Antithyroid Drug Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Antithyroid Drug Market Size Market Share by Type (2018-2023)
Table 32. APAC Antithyroid Drug Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Antithyroid Drug Market Size Market Share by Application (2018-2023)
Table 34. Europe Antithyroid Drug Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Antithyroid Drug Market Size Market Share by Country (2018-2023)
Table 36. Europe Antithyroid Drug Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Antithyroid Drug Market Size Market Share by Type (2018-2023)
Table 38. Europe Antithyroid Drug Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Antithyroid Drug Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Antithyroid Drug Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Antithyroid Drug Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Antithyroid Drug Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Antithyroid Drug Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Antithyroid Drug Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Antithyroid Drug Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Antithyroid Drug
Table 47. Key Market Challenges & Risks of Antithyroid Drug
Table 48. Key Industry Trends of Antithyroid Drug
Table 49. Global Antithyroid Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Antithyroid Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Antithyroid Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Antithyroid Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Shanghai Huanghai Pharmaceutical Co., Ltd Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 54. Shanghai Huanghai Pharmaceutical Co., Ltd Antithyroid Drug Product Offered
Table 55. Shanghai Huanghai Pharmaceutical Co., Ltd Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Shanghai Huanghai Pharmaceutical Co., Ltd Main Business
Table 57. Shanghai Huanghai Pharmaceutical Co., Ltd Latest Developments
Table 58. Merck KGaA Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 59. Merck KGaA Antithyroid Drug Product Offered
Table 60. Merck KGaA Main Business
Table 61. Merck KGaA Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Merck KGaA Latest Developments
Table 63. Lomapharm Rudolf Lohmann GmbH KG Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 64. Lomapharm Rudolf Lohmann GmbH KG Antithyroid Drug Product Offered
Table 65. Lomapharm Rudolf Lohmann GmbH KG Main Business
Table 66. Lomapharm Rudolf Lohmann GmbH KG Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Lomapharm Rudolf Lohmann GmbH KG Latest Developments
Table 68. Herbrand Pharmaceutical Chemistry Co., Ltd Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 69. Herbrand Pharmaceutical Chemistry Co., Ltd Antithyroid Drug Product Offered
Table 70. Herbrand Pharmaceutical Chemistry Co., Ltd Main Business
Table 71. Herbrand Pharmaceutical Chemistry Co., Ltd Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Herbrand Pharmaceutical Chemistry Co., Ltd Latest Developments
Table 73. Beijing Tongjida Pharmaceutical Co., Ltd Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 74. Beijing Tongjida Pharmaceutical Co., Ltd Antithyroid Drug Product Offered
Table 75. Beijing Tongjida Pharmaceutical Co., Ltd Main Business
Table 76. Beijing Tongjida Pharmaceutical Co., Ltd Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Beijing Tongjida Pharmaceutical Co., Ltd Latest Developments
Table 78. Shanghai Zhaohui Pharmaceutical Co., Ltd Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 79. Shanghai Zhaohui Pharmaceutical Co., Ltd Antithyroid Drug Product Offered
Table 80. Shanghai Zhaohui Pharmaceutical Co., Ltd Main Business
Table 81. Shanghai Zhaohui Pharmaceutical Co., Ltd Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Shanghai Zhaohui Pharmaceutical Co., Ltd Latest Developments
Table 83. Guangzhou Kanghe Pharmaceutical Co., Ltd Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 84. Guangzhou Kanghe Pharmaceutical Co., Ltd Antithyroid Drug Product Offered
Table 85. Guangzhou Kanghe Pharmaceutical Co., Ltd Main Business
Table 86. Guangzhou Kanghe Pharmaceutical Co., Ltd Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Guangzhou Kanghe Pharmaceutical Co., Ltd Latest Developments
Table 88. Hunan Hansen Pharmaceutical Co., Ltd Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 89. Hunan Hansen Pharmaceutical Co., Ltd Antithyroid Drug Product Offered
Table 90. Hunan Hansen Pharmaceutical Co., Ltd Main Business
Table 91. Hunan Hansen Pharmaceutical Co., Ltd Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Hunan Hansen Pharmaceutical Co., Ltd Latest Developments
Table 93. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 94. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Antithyroid Drug Product Offered
Table 95. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Main Business
Table 96. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Latest Developments
Table 98. Haimani Pharmaceutical Co., Ltd Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 99. Haimani Pharmaceutical Co., Ltd Antithyroid Drug Product Offered
Table 100. Haimani Pharmaceutical Co., Ltd Main Business
Table 101. Haimani Pharmaceutical Co., Ltd Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Haimani Pharmaceutical Co., Ltd Latest Developments
Table 103. Shanghai McLin Biochemical Technology Co., Ltd Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 104. Shanghai McLin Biochemical Technology Co., Ltd Antithyroid Drug Product Offered
Table 105. Shanghai McLin Biochemical Technology Co., Ltd Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Shanghai McLin Biochemical Technology Co., Ltd Main Business
Table 107. Shanghai McLin Biochemical Technology Co., Ltd Latest Developments
Table 108. Shanghai Yuanye Bio-Technology Co., Ltd Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 109. Shanghai Yuanye Bio-Technology Co., Ltd Antithyroid Drug Product Offered
Table 110. Shanghai Yuanye Bio-Technology Co., Ltd Main Business
Table 111. Shanghai Yuanye Bio-Technology Co., Ltd Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Shanghai Yuanye Bio-Technology Co., Ltd Latest Developments
Table 113. Amgen Inc Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 114. Amgen Inc Antithyroid Drug Product Offered
Table 115. Amgen Inc Main Business
Table 116. Amgen Inc Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Amgen Inc Latest Developments
Table 118. AbbVie Deutschland GmbH & Co.KG Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 119. AbbVie Deutschland GmbH & Co.KG Antithyroid Drug Product Offered
Table 120. AbbVie Deutschland GmbH & Co.KG Main Business
Table 121. AbbVie Deutschland GmbH & Co.KG Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. AbbVie Deutschland GmbH & Co.KG Latest Developments
Table 123. Centrix Pharmaceutical Inc. Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 124. Centrix Pharmaceutical Inc. Antithyroid Drug Product Offered
Table 125. Centrix Pharmaceutical Inc. Main Business
Table 126. Centrix Pharmaceutical Inc. Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Centrix Pharmaceutical Inc. Latest Developments
Table 128. Pfizer Inc. Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 129. Pfizer Inc. Antithyroid Drug Product Offered
Table 130. Pfizer Inc. Main Business
Table 131. Pfizer Inc. Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Pfizer Inc. Latest Developments
Table 133. Actavis Totowa LLC Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 134. Actavis Totowa LLC Antithyroid Drug Product Offered
Table 135. Actavis Totowa LLC Main Business
Table 136. Actavis Totowa LLC Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Actavis Totowa LLC Latest Developments
Table 138. Caraco Pharmaceutical Laboratories Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 139. Caraco Pharmaceutical Laboratories Antithyroid Drug Product Offered
Table 140. Caraco Pharmaceutical Laboratories Main Business
Table 141. Caraco Pharmaceutical Laboratories Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. Caraco Pharmaceutical Laboratories Latest Developments
Table 143. Boca Pharmacal Inc. Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 144. Boca Pharmacal Inc. Antithyroid Drug Product Offered
Table 145. Boca Pharmacal Inc. Main Business
Table 146. Boca Pharmacal Inc. Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 147. Boca Pharmacal Inc. Latest Developments
Table 148. Heritage Pharmaceuticals Inc. Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 149. Heritage Pharmaceuticals Inc. Antithyroid Drug Product Offered
Table 150. Heritage Pharmaceuticals Inc. Main Business
Table 151. Heritage Pharmaceuticals Inc. Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 152. Heritage Pharmaceuticals Inc. Latest Developments
Table 153. Par Pharmaceutical Inc Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 154. Par Pharmaceutical Inc Antithyroid Drug Product Offered
Table 155. Par Pharmaceutical Inc Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 156. Par Pharmaceutical Inc Main Business
Table 157. Par Pharmaceutical Inc Latest Developments
Table 158. Sandoz Pharmaceuticals Inc. Details, Company Type, Antithyroid Drug Area Served and Its Competitors
Table 159. Sandoz Pharmaceuticals Inc. Antithyroid Drug Product Offered
Table 160. Sandoz Pharmaceuticals Inc. Main Business
Table 161. Sandoz Pharmaceuticals Inc. Antithyroid Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 162. Sandoz Pharmaceuticals Inc. Latest Developments

LIST OF FIGURES

Figure 1. Antithyroid Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antithyroid Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Antithyroid Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Antithyroid Drug Sales Market Share by Country/Region (2022)
Figure 8. Antithyroid Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Antithyroid Drug Market Size Market Share by Type in 2022
Figure 10. Antithyroid Drug in Medical Treatment of Hyperthyroidism
Figure 11. Global Antithyroid Drug Market: Medical Treatment of Hyperthyroidism (2018-2023) & ($ Millions)
Figure 12. Antithyroid Drug in Preparation for Thyroid Surgery
Figure 13. Global Antithyroid Drug Market: Preparation for Thyroid Surgery (2018-2023) & ($ Millions)
Figure 14. Antithyroid Drug in Treatment of Thyroid Crisis
Figure 15. Global Antithyroid Drug Market: Treatment of Thyroid Crisis (2018-2023) & ($ Millions)
Figure 16. Global Antithyroid Drug Market Size Market Share by Application in 2022
Figure 17. Global Antithyroid Drug Revenue Market Share by Player in 2022
Figure 18. Global Antithyroid Drug Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Antithyroid Drug Market Size 2018-2023 ($ Millions)
Figure 20. APAC Antithyroid Drug Market Size 2018-2023 ($ Millions)
Figure 21. Europe Antithyroid Drug Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Antithyroid Drug Market Size 2018-2023 ($ Millions)
Figure 23. Americas Antithyroid Drug Value Market Share by Country in 2022
Figure 24. United States Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Antithyroid Drug Market Size Market Share by Region in 2022
Figure 29. APAC Antithyroid Drug Market Size Market Share by Type in 2022
Figure 30. APAC Antithyroid Drug Market Size Market Share by Application in 2022
Figure 31. China Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Antithyroid Drug Market Size Market Share by Country in 2022
Figure 38. Europe Antithyroid Drug Market Size Market Share by Type (2018-2023)
Figure 39. Europe Antithyroid Drug Market Size Market Share by Application (2018-2023)
Figure 40. Germany Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Antithyroid Drug Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Antithyroid Drug Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Antithyroid Drug Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Antithyroid Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 54. APAC Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 55. Europe Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 57. United States Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 58. Canada Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 61. China Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 62. Japan Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 63. Korea Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 65. India Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 66. Australia Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 67. Germany Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 68. France Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 69. UK Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 70. Italy Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 71. Russia Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 72. Spain Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 75. Israel Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Antithyroid Drug Market Size 2024-2029 ($ Millions)
Figure 78. Global Antithyroid Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Antithyroid Drug Market Size Market Share Forecast by Application (2024-2029)


More Publications